~~<i id='2A9CF1B17D'><strike id='2A9CF1B17D'><tt id='2A9CF1B17D'><pre id='2A9CF1B17D'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

focus

leisure time

author：leisure time 2025-08-23 08:57:35 - browse：55

Blue nerve cell surrounded by red antibodies. -- health coverage from STAT — Adobe

Belgian drugmaker Argenx said Monday that its antibody treatment called Vyvgart significantly delayed the progression of an autoimmune nerve disorder that causes people to lose feeling and muscle strength in the arms and legs.

The positive outcome — a 61% reduction in the risk of relapse compared to a placebo — achieved the main goal of a Phase 3 clinical trial designed to demonstrate Vyvgart’s benefit for patients with chronic inflammatory demyelinating polyneuropathy, or CIDP.

“We hit the bullseye,” said Argenx CEO Tim Van Hauwermeiren.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Medical leaders decry Supreme Court decision on affirmative action
Next article： Medical leaders decry Supreme Court decision on affirmative action

leisure time

explore

entertainment

focus

leisure time

hotspot

CMSAdministratorChiquitaBrooks-LaSureChipSomodevilla/GettyImagesWASHINGTON— EliLilly’slatestanti-amy

WSS

State Dept. review finds Biden bears some blame for Afghanistan failures

Jerome Adams on the need for new antivirals for Covid

Infectious disease expert Jeanne Marrazzo assumes Fauci role

State Dept. review finds Biden bears some blame for Afghanistan failures

Listen: Biogen's situation, Wegovy's risks, & biotech insider trading

Amazon expands telehealth clinic nationwide

focus

leisure time

leisure time

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Infectious disease expert Jeanne Marrazzo assumes Fauci role

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Affirmative action in medical school literally saved lives

Drug repurposing or repositioning? The language matters

As demand for Covid shots wanes, Moderna seeks its next success

Wildfire smoke exposes gaps in outdoor worker protections

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

New air purifier tech could be key to improving indoor air quality

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

explore

EQRx, failed developer of low

In age of alternative facts, a scholarly course on calling out crap

What the airline industry can learn from medicine

Medicare proposal to cover medical devices draws a mixed reaction

Scientists inch closer to single

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

entertainment

focus

leisure time

hotspot